Wu Xiaocheng, Matanoski Genevieve, Chen Vivien W, Saraiya Mona, Coughlin Steven S, King Jessica B, Tao Xu-Guang
Louisiana Tumor Registry, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA.
Cancer. 2008 Nov 15;113(10 Suppl):2873-82. doi: 10.1002/cncr.23757.
Vaginal cancer is a rare malignancy. It has many of the same risk factors as cervical cancer, including a strong association with persistent human papillomavirus infection. Descriptive studies of the epidemiology of vaginal cancer are scarce in the literature.
The 1998 through 2003 incidence data from 39 population-based cancer registries were used, covering up to 83% of the US population. The 1996 through 2003 data from 17 cancer registries were used for survival analysis. Incidence rates, disease stage, and 5-year relative survival rates were calculated by race, ethnicity, and age group. Data analysis focused mainly on squamous cell carcinoma (SCC).
Incidence rates for all vaginal cancers combined were 0.18 per 100,000 female population for in situ cases and 0.69 for invasive cases. The median age of invasive cases was older than that of in situ cases (aged 68 years vs 58 years). SCC was the most common histologic type (71% of in situ cases and 66% of invasive cases). Compared with the rate for white women, the age-adjusted incidence rate of invasive SCC was 72% higher (P < .05) among black women, whereas the rate among Asian/Pacific Islander (API) women was 34% lower (P < .05). Hispanic women had a 38% higher rate than non-Hispanic women (P < .05) of invasive SCC. The rates for in situ SCC peaked at age 70 years and then declined, whereas the rates of invasive SCC increased continuously with advancing age. Black, API, and Hispanic women as well as older women were more likely to be diagnosed with late-stage disease, and these groups had lower 5-year relative survival rates than their white, non-Hispanic, and younger counterparts.
Incidence rates of vaginal SCC varied significantly by race, ethnicity, and age group. Black, API, and Hispanic women as well as older women had a high proportion of late-stage disease and a low 5-year survival rate.
阴道癌是一种罕见的恶性肿瘤。它与宫颈癌有许多相同的危险因素,包括与持续性人乳头瘤病毒感染密切相关。文献中关于阴道癌流行病学的描述性研究很少。
使用了1998年至2003年来自39个基于人群的癌症登记处的发病率数据,覆盖了美国高达83%的人口。使用了1996年至2003年来自17个癌症登记处的数据进行生存分析。按种族、族裔和年龄组计算发病率、疾病分期和5年相对生存率。数据分析主要集中在鳞状细胞癌(SCC)。
所有阴道癌合并原位病例的发病率为每10万女性人口0.18例,浸润性病例为0.69例。浸润性病例的中位年龄高于原位病例(分别为68岁和58岁)。SCC是最常见的组织学类型(原位病例的71%和浸润性病例的66%)。与白人女性相比,黑人女性浸润性SCC的年龄调整发病率高72%(P <.05),而亚裔/太平洋岛民(API)女性的发病率低34%(P <.05)。西班牙裔女性浸润性SCC的发病率比非西班牙裔女性高38%(P <.05)。原位SCC的发病率在70岁时达到峰值,然后下降,而浸润性SCC的发病率随年龄增长持续上升。黑人、API和西班牙裔女性以及老年女性更有可能被诊断为晚期疾病,并且这些群体的5年相对生存率低于白人、非西班牙裔和年轻女性。
阴道SCC的发病率因种族、族裔和年龄组而异。黑人、API和西班牙裔女性以及老年女性晚期疾病比例高,5年生存率低。